Revista UNICIENCIA
Uniciencia Vol. 36(1), January-December, 2022
E-ISSN: 2215-3470
DOI: https://dx.doi.org/10.15359/ru.36-1.30
A Systematic Review About the Contribution of The Genus Tessaria (Asteraceae) To Cancer Study and Treatment
Revisión sistemática sobre la contribución del género Tessaria (Asteraceae) al estudio y tratamiento del cáncer
Revisão sistemática sobre a contribuição do gênero Vernonia condensada Baker (Asteraceae) para o estudo e tratamento do câncer
Arianna Sosa-Lochedino1, María Belén Hapon1,2, Carlos Gamarra-Luques1,3*
Received: Aug/12/2021 • Accepted: Oct/27/2021 • Published: Jun/01/2022
Abstract Belonging to the Asteraceae family, Tessaria (Ruiz & Pavon, 1753) is a genus of shrubs or small trees distributed in various habitats located from Argentina to the southwestern United States of America. The taxa are composed of five confirmed species, which have been previously reported for their ethnopharmacological uses as hypocholesterolemiant, hypoglycemic, antitussive, anti-inflammatory, anticancer, and abortifacient agent; it also has been used in hepatic, renal, pulmonary, and rheumatic diseases. Up to the present, T. absinthioides, T. ambigua, T. dodoneifolia, T. fastigiata and T. integrifolia have been chemically analyzed. While decoctions, infusions, methanolic, and hydromethanolic extracts are the most studied botanical compounds, its most recognized phytochemical constituents are caffeoylquinic acid, eupatorin, naringenin, protocatechuic, and quercetin. Scientifically, several biomedical properties such as virucidal, antibacterial, leishmanicidal, insecticidal, gastroprotective, antiasthmatic, hypoglycemic, and antiatherogenic were attributed to the genus. Concerning oncologic research, the chemicals produced by Tessaria have antitumor activities interfering with carcinogenesis, cell proliferation, metastasis, and angiogenesis. In addition, the natural extracts obtained from Tessaria species have biological activities closely related to cancer, acting as antioxidants and anti-inflammatories. In particular, it has been reported that T. absinthioides resulted cytotoxic against several cancer cell lines and acts as an antitumoral compound in murine models. Due to the aforementioned antecedents, the Tessaria species are considered undervalued within the oncological field; the goal of the current systematic review is to summarize the information available on the genus, relevant for cancer research and treatment. Keywords: pájaro bobo; native plants; ethnopharmacology; oncology; herbal medicines; complementary medicine Resumen Perteneciente a la familia Asteraceae, Tessaria (Ruiz & Pavon, 1753) es un género de arbustos o árboles pequeños distribuidos en diversos hábitats ubicados desde Argentina hasta el suroeste de los Estados Unidos de América. El taxón está compuesto por cinco especies confirmadas, las cuales han sido previamente reportadas por sus usos etnofarmacológicos como hipocolesterolemiante, hipoglucemiante, antitusivo, antiinflamatorio, anticanceroso y abortivo; así como en enfermedades hepáticas, renales, pulmonares y reumáticas. Hasta el momento, se han analizado químicamente T. absinthioides, T. ambigua, T. dodoneifolia, T. fastigiata y T. integrifolia. Mientras que las decocciones, infusiones, extractos metanólicos e hidrometanólicos son los compuestos botánicos más estudiados; sus constituyentes fitoquímicos más reconocidos son el ácido cafeolquínico, eupatorina, naringenina, protocatechuic y quercetina. Científicamente, se atribuyeron al género varias propiedades biomédicas como virucida, antibacteriano, leishmanicida, insecticida, gastroprotector, antiasmático, hipoglucemiante y antiaterogénico. En relación con la investigación oncológica, las sustancias químicas producidas por Tessaria, tienen actividades antitumorales que interfieren con la carcinogénesis, la proliferación celular, la metástasis y la angiogénesis. Además, los extractos naturales obtenidos de estas especies tienen actividades biológicas estrechamente relacionadas con el cáncer y actúan como antioxidantes y antiinflamatorios. En particular, se ha informado que T. absinthioides resulta citotóxico contra varias líneas de células cancerosas y actúa como compuesto antitumoral en modelos murinos. Debido a los antecedentes mencionados, se considera la especie Tessaria como infravalorada dentro del campo oncológico. El objetivo de la presente revisión sistemática es resumir la información disponible del género, relevante para la investigación y el tratamiento del cáncer. Keywords: Pájaro bobo; plantas autóctonas; etnofarmacología; oncología; medicamentos herbarios; medicina complementaria Resumo Pertencente à família Asteraceae, a Vernonia (Ruiz & Pavon, 1753) é um gênero de arbustos ou pequenas árvores distribuídas em vários habitats localizados da Argentina ao sudoeste dos Estados Unidos da América. O táxon é composto por cinco espécies confirmadas, que foram previamente relatadas para seus usos etnofarmacológicos como hipocolesterolemiante, hipoglicêmico, antitussivo, anti-inflamatório, anticâncer e abortivo; assim como em doenças hepáticas, renais, pulmonares e reumáticas. Até agora, foram analisados quimicamente T. absinthioides, T. ambigua, T. dodoneifolia, T. fastigiata e T. integrifolia. Por outro lado, as decocções, infusões, extratos metanólicos e hidrometanólicos são os compostos botânicos mais estudados; seus constituintes fitoquímicos mais reconhecidos são: ácido cafeoilquínico, eupatorina, naringenina, protocatecuico e quercetina. Cientificamente, várias propriedades biomédicas foram atribuídas ao gênero como viricida, antibacteriana, leishmanicida, inseticida, gastroprotetor, antiasmática, hipoglicêmica e antiaterógena. Com relação à pesquisa sobre câncer, os produtos químicos produzidos pela Venonia têm atividades antitumorais que interferem na carcinogênese, proliferação celular, metástase e angiogênese. Além disso, extratos naturais obtidos dessas espécies têm atividades biológicas intimamente relacionadas com o câncer e atuam como antioxidantes e anti-inflamatórios. Em particular, t. absinthioides tem sido relatado como citotóxico contra várias linhas de células cancerosas e age como um composto antitumoral em modelos murinos. Devido ao passado supracitado, a espécie Vernonia é considerada desvalorizada dentro do campo oncológico. O objetivo desta revisão sistemática é resumir as informações do gênero disponíveis relevantes para a pesquisa e o tratamento do câncer. Keywords: Boldo baiano; plantas nativas; etnofarmacologia; oncologia; fitoterápicos; medicina complementar |
Cancer is a leading cause of death in the world. Despite synthetic drugs used in current therapies have improved patient prognosis, the toxicity and development of secondary resistance remain a serious concern for researchers (Qazi et al., 2018). It is generally accepted that plant-derived products provide health-related benefits, specifically for the prevention and treatment of several diseases. Crude herbal or botanical preparations have shown promising utility for chronic illnesses such as oncologic disorders, diabetes, heart diseases, and neurodegenerative processes, among others. The herbal bioactive compounds can provoke changes in plasma nutrient availability, therefore, in the cell microenvironment. By this mode of action, botanicals became a valuable source of anticancer compounds, which can affect tumor growth by modifications induced in antitumor immune response, cancer cell proliferation, its survival, and spread (Kanarek et al., 2020). The mentioned properties are supported by numerous preclinical studies, which provide ample evidence that botanicals regulate multiple cancer hallmark pathways, including cell cycle, apoptosis, angiogenesis, invasion, and metastasis (Puccinelli & Stan, 2017).
In addition, these natural compounds can also interfere with the early stages of tumor development, acting as chemopreventive agents (Butt et al., 2013). Carcinogenesis is a biological process hallmarked by its diffuse and multifocal presence, with high statistical chances to progress to malignancy, alterated DNA synthesis, and changes in cell protection mechanisms (Ryan & Faupel-Badger, 2016). This process, in which the normal cell is transformed into a cancer cell, is commonly divided into 3 different stages: initiation, promotion, and progression (Weinstein et al., 1984). Among an increased list of chemical and environmental carcinogens, inflammation is a factor widely related to neoplastic transformation. In the interplay between inflammation and cancer, reactive oxygen/nitrogen species, cytokines and prostaglandins act as promotors of carcinogenesis by induction of DNA damage. The interference with the inflammatory process and its intermediaries will reduce the tumor transformation, neoplastic progression, and the development of metastases and recurrences (Piotrowski et al., 2020). For this reason, anti-inflammatory and anti-oxidant properties of botanic extracts could represent a crucial aid for the prevention of carcinogenesis mediated by the inflammatory processes (Serrano et al., 2018).
The plant kingdom represents an endless supply of bioactive compounds with potential activity to control diseases. In particular, the Asteraceae family includes more than 20 thousand species around the world and is considered the most evolved botanical family due to the floral structure and its chemical composition. In America, it is within the most important families of plants in relation to the number of species reported with medicinal properties (Thomas et al., 2009). Tessaria (Ruiz & Pavon, 1753) is a genus of the Asteraceae family, sometimes considered as Pluchea, composed of up to 17 proposed species. It is distributed from the southwest of the United States to Argentina; including Brazil, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Panamá, Paraguay, Perú, Uruguay, and Venezuela (Tropicos.org, 1982). Currently, there are only 5 accepted and confirmed species: T. absinthioides (Hook. & Arn.) DC.; T. ambigua DC.; T. dodoneifolia (Hook. & Arn.) Cabrera; T. fastigiata (Griseb.) Cabrera and T. integrifolia Ruiz & Pav (The Plant List, 2013). All these species are reported in the bibliography by their health care implications and, often, scientific studies demonstrate novel valuable biological properties. Because of the mentioned antecedents, considering the Tessaria species as undervalued within the oncologic field, the goal of the current systematic review is to summarize the available genus information relevant to cancer research and treatment.
A literature search on the Tessaria genus was performed to identify texts describing species with ethnopharmacological reports of use and other papers related to its scientific studies. The current review includes 77 references selected from websites (The plant list and Tropicos.org) and scientific databases as PubMed, Science Direct, SciELO, Google Scholar, LILACS, and Library Genesis. The main descriptors used were Tessaria and the constitutive genus species (especially, T. absinthioides, T. ambigua, T. dodoneifolia, T. fastigiata, and T. integrifolia), cancer, cytotoxicity, antitumoral, carcinogenesis, tumor growth, metastasis, angiogenesis, and, finally, other words related to the chemical characterization as phytochemicals, phenolic compounds, and all the specific compounds mentioned in Table 3. Altogether, more than 4500 articles and documents were reviewed.
Distribution and Ethnopharmacological Uses of Tessaria spp.
Cancer is a group of diseases that represent a worldwide problem and, often, conventional therapy is limited by the cost and side effects of used drugs. With few exceptions, folk medicine has not reported information about cancer diagnosis and treatment. Because of this, exploring plants with registered ethnobotanical properties resulted an important strategy to find effective natural products for oncologic purposes. For this reason, during the last decades, many plants with reports of ethnomedicinal use were studied to develop anticancer plant-based drugs with improved potency and better tolerance by the patients (Tariq et al., 2017).
Because the natural distribution of Tessaria spp. includes regions and cultures of Mesoamerica and South America, the ethnopharmacological properties of the species are widely registered (Table 1). Among others, there are reports of biological actions related to inflammation, cell proliferation, immune system response, and liver and kidney protection. Because of the relation between these properties and the tumor growth or treatment toxicity, the mentioned attributes make the genus a valuable candidate for plant-based cancer research.
Table 1
Ethnopharmacological Information of Tessaria Tessaria spp.
Species |
Popular names |
Ethnopharmacological uses |
Product |
Geographical distribution |
Ref. |
T. absinthioides |
Pájaro bobo, chilca, suncho rosado, suncho negro, brea |
Hypocholesterolemiant, balsamic, expectorant |
Dried leaves infusion |
Argentina |
|
Sorona, brea |
Diabetes |
Leaves infusion |
Chile |
||
Pájaro bobo, suncho negro |
Empacho (digestive disorder) |
Leaves infusion |
Argentina |
||
Pájaro bobo, Sorona, hierba de zorra |
Rheumatism, prostate illness, cancer, |
Leaves infusion |
Perú, Bolivia, Chile, Argentina |
||
T. ambigua |
Pájaro bovo |
Antitussive, hepatic, tonic, depurative, laxative |
Part not specified |
Argentina |
|
T. dodonefolia |
hierba dulce, ka´a he´ê |
sweetening |
Young shoots |
Paraguay |
|
Chilca dulce,suncho, chilca, chilca negra, suncho negro |
abortifacient, vaginal mycosis, anuria, urin with blood, emmenagogue |
Leaf |
Argentina |
||
T. fastigiata |
Uri uri |
antiinfflammatory |
Part not specified |
Bolivia |
|
T. integrifolia |
Pájaro bobo |
hepatic and renal insufficiency, hepatitis. |
Leaves |
Perú |
|
Aliso del río, aliso, aliso bobo, bobo, buibé, pájaro bobo, palo bobo |
Diuretic, asthma, febrifuge, astringent, cicatrizant |
Aereal parts infusion |
Argentina |
||
Antigonorrheal, antiallergic,antiasthmatic, antiinflammatory, diuretic |
Leaf and flowers |
Argentina, Peru |
|||
--- |
Malnutrición |
All plant |
Bolivia |
||
pájaro bobo, huapariu, tseco |
asthma, antipiretic, antiinflammatory, diuretic |
Part not specified |
Perú |
Note: derived from research.
Reported Biomedical Properties Of Tessaria Species Different From Cancer
Considering that cancer is a very heterogeneous group of diseases, it is not possible to predict when future discoveries will report other activities of Tessaria spp. relevant for oncology. For this reason, Table 2 summarizes the available information about other biomedical, scientifically tested properties of the genus.
Table 2
Biomedical properties of Tessaria spp. not cancer related.
Specie |
Activity |
Plant source |
Cite |
T.abs. |
Insecticidal and repelent |
Sesquiterpenes from aerial parts. |
|
Virucidal |
Essential oils from leaves. |
||
Organic extract (dichloromethane: methanol) |
|||
Gastric cytoprotection |
Sesquiterpenes from aerial parts. |
||
Antibacterial |
Methanolic extract from leaves |
||
Hypoglycemic and antiatherogenic |
Aqueous extract from leaves |
||
T.amb. |
Insecticidal |
Penduletin from aerial parts |
|
T.dod. |
Antifungal |
Flavonones from aerial parts |
|
T.fas. |
Antiasthmatic, analgesic, immunomodulatory |
Casticin from leaves |
|
T.int. |
Antispasmodic |
Aqueous extract from aerial parts |
|
Gastric cytoprotection |
Ethanolic extract from leaves |
||
Leishmanicidal |
Sesquiterpenes from leaves |
T. abs.: T. absinthioides; T. amb.: T. ambigua; T. dod.: T. dodoneifolia; T. fas.: T. fastigiata; T. int.: T. integrifolia.
Note: derived from research.
Antioncologic Effects Of Tessaria spp.
Cancer is caused by a multistep process that results in uncontrolled cell proliferation. The available information about Tessaria species effects concerning cancer establishment and progression is schematized in Figure 1. To the present, only 4 species have been scientifically studied for biological activities with oncological relevance; in these cases, the natural compounds demonstrated anticarcinogenic, cytotoxic, and antitumoral properties. According to our knowledge, T. ambigua has no previous reports of biological properties related to cancer.
Figure 1. Antioncologic Effects of Tessaria spp.
Note: derived from research.
The Role of the Tessaria Genus in Carcinogenesis
In some opportunities, the carcinogenesis process is driven by oxidative stress and inflammation, which determines the aberrant gene expression of tumor cells and those sites surrounding the lesion (Lechner & Stoner, 2019). As with other plants, Tessaria species are a source of phenolic compounds reported as natural antioxidants with clear inhibitory effects of carcinogenesis.
T. absinthioides is the most studied specimen because of its anti-inflammatory and antioxidant properties. Torres Carro et al. (2015; 2017) evidenced the capability of the hydromethanolic extracts obtained from the plant aerial parts to interfere with the inflammation process. Extracts act by a reduction in the activity of the pro-inflammatory enzymes lipoxygenase (LOX), cyclooxygenase (COX-2), secretory phospholipase A2 (PLA2), and hyaluronidase. Moreover, diminished production of nitric oxide (NO) by a reduction in the activity of nitric oxide synthase enzyme (iNOS) and the stabilization of human red blood cells membrane was also demonstrated. In the same studies, the antioxidant capability of hydromethanolic extract was established by determining the iron-chelating capacity and the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging effect. Later, Gómez et al. (2019) confirmed the antioxidant power of Argentinean and Chilean T. absinthioides decoctions by 2,2 diphenyl picrylhydrazyl (DPPH) scavenging activity, ferric reducing antioxidant power assay (FRAP), Trolox Equivalent Antioxidant Activity (TEAC), and reduction of lipid peroxidation in human erythrocytes. The above-mentioned biological properties were attributed to the presence of caffeoylquinic acid derivatives, as well as vanillic acid, protocatechuic, taxifolin, chlorogenic acid, quercetin, and rutin, among other phenolic compounds evidenced in the extracts.
In T. integrifolia, the antioxidant and anti-inflammatory properties were demonstrated by studying changes in the migration and the superoxide anion secretion of activated human macrophages. In this work, the biological properties were also related to the caffeoylquinic acid present in the aerial parts of the plant (Peluso et al., 1995). Later, Ono et al. (2000) described the antioxidants effects of eudesmane derivatives present in the methanolic extract obtained from leaves, evidenced by the ferric thiocyanate method and DPPH scavenging assay.
T. fastigiata is the other species in the genus reported as an antioxidant. The unique available study used DPPH scavenging activity, nitroblue tetrazolium (NBT)/hypoxanthine superoxide assay, and the hydroxyl radical scavenging activity to evidence the biological activity attributable to the phenolic compounds present in the leaves hydromethanolic extract.
Altogether, the presented evidence makes Tessaria plants a very important source of natural compounds to prevent biological oxidations and inflammation, reducing the impact of both key factors of carcinogenesis.
Cytotoxicity of Tessaria Genus Against in Vitro Cells
In recent times, an important scientific effort was focused on discovering novel, effective, and affordable anticancer agents from natural sources. Because of this, a large number of botanicals have been explored for their cytotoxic potential against in vitro models of cancer cells (Dehelean et al., 2021). In this section, the available evidence of cytotoxicity is analyzed in relation to the capability of make interference in cancer cell metabolism, the inhibition of cell proliferation, and the cell death induction.
Between the reviewed Tessaria species, the evidence clearly indicates that botanicals exert a selective cytotoxic effect against cancer cells. By these results it was demonstrated that the treatment with natural compounds of normal, non-tumoral cells induces lower or null toxicity; in contrast, when cancer cell lines were assayed, the cytotoxic effects were potent, similar to those evidenced by the conventional chemotherapeutic drugs used as a positive control.
Persia et al. (2017) demonstrated the selective cytotoxic effects of T. absinthioides leaves aqueous extract. The study reported a dose-response effect on HeLa (cervix cancer), Gli-36 (glioblastoma), HCT-116 (colorectal cancer) and MCF-7 (breast cancer) human cancer cell lines. The extract potency, measured as CV50 (50% of cell viability) in all cases, was similar to 5-fluoracile, a chemotherapic agent used as a positive control. Interestingly, in the same study and conditions, the cytotoxicity determined by the extract on non-tumoral HBL-100 cell line was significantly lower in relation to the other cancer cell lines tested; also, in these cell lines, the measured toxicity was notably diminished in relation to the effect induced by 5-fluoracile.
In another study, eudesmane semi-synthetic derivatives from T. absinthioides affected the proliferation of A2780 (ovarian), HeLa (cervix), SW1573 (non-small cell lung), T47D (breast) and WiDr (colorectal) human solid tumor cell lines. In a dose-response experimental design, the treatment determined metabolic cytotoxicity (measured by SRB assay) and cell cycle arrest in G2/M phase. In the study, 5-fluoracil was used as positive control, and its potency, measured as GI50 (50% of growth inhibition), was always lower than the plant-derived compound (León et al., 2009).
There are, at least, other 3 works of in vitro studies related to the cytotoxicity of Tessaria´s compounds. In the course of these studies, not directly related to cancer research, were tested caffeoylquinic derivatives and flavonoids from T. absinthioides (Torres Carro et al., 2015), caffeoylquinic derivatives from T. integrifolia (Peluso et al., 1995) and the ethanolic extract of T. dodoneifolia with content of naringenin and pinocembrin (Soberón et al., 2020). In all of these studies was reported none or slight toxicity induced by treatment on cultured non-tumoral murine macrophages and human peripheral blood lymphocytes (PBL).
The presented evidence in this section for the Tessaria derived compounds coincides with the observation of the selective cytotoxicity against cancer cells, originally proposed by Persia et al. (2017).
Preclinical Evidence AboutTessaria sp. Antitumoral Effects
Often, the therapeutic potential of some natural products is limited by the presence of xenobiotics’ effects. In other cases, the in vitro evidenced cytotoxic properties cannot be reproduced in vivo because of bioavailability limitations of the bioactive phytoconstituents (Piroozmand et al., 2020). In the case of T. absinthioides, both limitations were analyzed on the aqueous extract by the study of oral toxicity and by the determination of its antitumoral effects against colorectal-induced cancer. The T. absinthoides aqueous extract oral toxicity was tested and discarded in males and females of Sprague Dawley rats. At doses up to 2000 mg kg-1, a single administration of T. absinthioides did not determine acute toxic effects. No animals died immediately or within 14 days after administration and were not evidenced changes of body weight nor other clinical signs of toxicity. After euthanasia, necropsy did not evidence changes on tissues or organs. On the other hand, the study of 28 oral repeated doses up to 1000 mg kg-1 d-1 did not show toxic evidence either. After administration, no significant changes were registered in body weight, organs weight or organs histological appearance. Neither changes were present in blood cell counting nor blood serum biochemistry (Persia et al., 2017).
T. integrifolia inflorescences infusion was also tested by its oral toxicity in the 28 days repeated doses experimental design. By the use of Rattus norvegicus var. albina, the study concluded that no significant toxic effects were observed in the males or females analyzed. After administration of 500 mg kg-1 day-1 doses, the histopathologic analysis showed neither cell damage nor necrosis in the liver, lungs, stomach, brain, ovary or testis. Only a mild to moderate glomerular congestion was evidenced and was attributable to the sesquiterpene lactones present in the plant sample. In conclusion, the study demonstrated that there was not significant toxicity determined by oral administration of T. integrifolia during 28 days and for the long term administration of the infusion, specific studies need to be performed to discard potential kidney damages (Julián Dávalos & Vásquez Muñoz, 2016).
About the in vivo antitumoral effects, T. absinthioides aqueous extract was tested in a colorectal cancer model induced by dimethylhydracine (DMH). In BALC/c mice, the oral administration of 300 mg animal-1 day-1 significantly increased the median survival of animals. While the median survival in Tessaria treated animals was 30 weeks, in the untreated group survival was significantly lower (24 weeks). It is important to note that 5-fluoracil was used as a positive control drug; in this group, the median survival was 27 weeks. In spite of the fact that no statistical differences were observed between the survival of Tessaria and 5-fluoracil groups, the in vivo results confirm the similar potency evidenced by both compounds in vitro. To finish, animals treated with Tessaria did not evidence toxic symptoms related to the oral administration of the extract during the entire assay (up to 38 weeks) (Persia et al., 2017).
Only preliminary evidence exists about T. absinthioides efficiency against in situ and metastatic murine syngeneic melanomas (personal observations); until now, no other Tessaria species were reported in the bibliography by its antitumoral properties.
Tessaria Genus as the Origin of Anticancer Phytochemicals
The phytochemicals are bioactive non-nutrient vegetal compounds that have health-related effects. More than 5,000 phytochemicals have been identified; if well, their health benefits are still to be fully understood. Several studies have strongly demonstrated that phytochemicals have many different mechanisms of action related to cancer (Liu, 2004).
Table 3 presents the phytochemicals derived from Tessaria spp. with reported anticancer actions. Until now, the 5 confirmed species of the genus (T. absinthioides, T. ambigua, T. dodonaeifolia, T. fastigiata, and T. integrifolia), were chemically analyzed and their phytochemical constituents described (Torres-Carro et al., 2017; García et al., 2003a; Gómez et al., 2019; Ono et al., 2007; Guerreiro et al., 1990; Bailac et al., 1998; Caballero Palacios, 2014). By these studies, more than 30 phenolic compounds were identified in Tessaria with reported anticancer efficacy, including sesquiterpenes, flavonoids, phenolic acids, and lignans. All of these chemicals affect tumor growth, modifying proliferation or viability; while 15 compounds interfere with carcinogenesis, 10 reduce the metastasis process, and 8 decrease angiogenesis.
Table 3
Tessaria spp. Phytochemicals and Its Anticancer Properties.
Phytochemical |
Source |
Anticancer effect by target… |
Ref |
|||
carcinogenesis |
tumor growth |
metastasis |
angiogenesis |
|||
Amyrin |
T. amb. |
yes |
||||
Artemisinin |
T. abs. |
yes |
yes |
yes |
||
Caffeoylquinic acid and derivatives |
T. abs. |
yes |
yes |
|||
Caryophyllene oxide |
T. abs. |
yes |
yes |
|||
Casticin |
T. abs. |
yes |
yes |
yes |
yes |
|
Chrysosphanol |
T. int. |
yes |
yes |
yes |
||
Citric acid |
T. abs. |
yes |
||||
Enoic acid derivatives |
T. abs. |
yes |
yes |
|||
Eriodictyol |
T. dod. |
yes |
yes |
yes |
||
Eudesmane derivatives |
T. abs. |
yes |
yes |
yes |
yes |
|
Eudesmol (gamma) |
T. abs. |
yes |
||||
Eugenol |
T. int. |
yes |
||||
Eupatorin |
T. abs. |
yes |
yes |
yes |
||
Gallic acid |
T. int. |
yes |
||||
Ginnalin A |
T. abs. |
yes |
yes |
|||
Gurjunene (alfa) |
T. abs. |
yes |
yes |
|||
Hyperyn |
T. int. |
yes |
||||
Ilicic acid |
T. abs. |
yes |
||||
Linalool |
T. int. |
yes |
||||
Mannoheptulose |
T. abs. |
yes |
||||
Naringenin |
T. dod. |
yes |
yes |
yes |
yes |
|
Pinoresinol |
T. int. |
yes |
yes |
|||
Protocathechuic |
T. abs. |
yes |
yes |
|||
Quercetin |
T. dod. |
yes |
yes |
yes |
yes |
|
Rhamnetin |
T. abs. |
yes |
yes |
|||
Sakuranetin |
T. dod. |
yes |
yes |
|||
Taxifolin |
T. abs. |
yes |
yes |
yes |
||
Terpinen-4-ol |
T. abs. |
yes |
||||
Tessaric acid and derivatives |
T. abs. |
yes |
||||
Trifolin |
T. int. |
yes |
||||
Vanillic acid |
T. abs. |
yes |
yes |
yes |
T. abs.: T. absinthioides; T. amb.: T. ambigua; T. dod.: T. dodoneifolia; T. fas.: T. fastigiata; T. int.: T. integrifolia
Note: derived from research.
The above-mentioned phytochemicals and their scientifically proven effects make the genus Tessaria a valuable source of natural compounds for future cancer research and treatment.
Botanicals, nutraceuticals, and herbals are plant-derived materials with medical benefits that aim for disease prevention or treatment. They represent a particular promise for cancer prevention due to their efficacy and safety profile. The wide chemical diversity features together with available epidemiological, preclinical, and clinical studies suggest an undeniable role of natural products in various approaches related to cancer prevention and treatment. Many of these natural compounds are responsible for antioxidant, anti-inflammatory, chemopreventive, and anticancer activities. Some botanical constituents as polyphenols, phytoalexins, carotenoids, and flavonoids are specifically related to the expression and activity of multiple proteins such as epidermal growth factor receptor (EGFR), nuclear factor-kappa B (NF-κB), tumor necrosis factor-alpha (TNF-α), protein kinase B (PKB/AKT), mitogen-activated protein kinase (MAPK) and p53, between others targets. By the modification of these molecular targets, botanicals play a critical role in signal transduction pathways related to carcinogenesis, cell proliferation inhibition, invasion, and angiogenesis (Rahman et al., 2010).
Due to these important properties, it is urgent to perform a scientific validation of regional medicinal plants to precise their toxicological and pharmacological profiles with the goal of ensuring both the effectiveness and the safety in the use of ethnobotanicals. This information is highly valuable and necessary to improve the therapeutic approach of pathologies with unsatisfactory or toxic treatments, mainly cancer. In this field, the botanical complementary treatments rise as a promissory area to improve the potency of available therapies and/or reduce their toxic collateral effects.
The present review systematically summarizes the information available for the Tessaria genus related to cancer research and treatment. Then, it is imperative to move forward to complete the preclinical evidence related to its molecular mechanistic mode of action, pharmaceutical presentation and standardization, and the study of pharmacological interactions with current chemotherapeutics. In accordance with the presented evidence, based on its ethnopharmacological reports, biomedical explored properties, and phytochemical composition, it is possible to affirm that Tessaria spp represent a promissory source of botanicals for oncologic purposes, especially in the complementary treatment approach. To conclude, based on the folkloric reports of uses and the recently validated scientific information, the present revision intends to encourage new and deep research destined to promote the Tessaria derived botanicals as anticancer compounds.
The authors declare no competing interests.
All the authors declare that the final version of this paper was read and approved.
The total contribution percentage for the conceptualization, preparation, and correction of this paper was as follows: A.S.L. 25 %, M.B.H 25 % and C.G.L. 50 %.
Data sharing is not applicable since no new data was created or analyzed in this study.
Bailac, P., Duschatzky, C., Carrascull, A., Ponzi, M. & Firpo, N. (1998). Composition of the Essential Oils of Tessaria absinthioides (Hook et Arn.) D. Candole. Journal of essential oil Research, 10(1), 89-91. https://doi.org/10.1080/10412905.1998.9700848
Barboza, G. E., Cantero, J. J., Núñez, C., Pacciaroni, A. & Ariza Espinar, L. (2009) Medicinal plants: A general review and a phytochemical and ethnopharmacological screening of the native Argentine Flora. Kurtziana, 34(1-2), 7-365.
Bi, W., He, C. N., Li, X. X., Zhou, L. Y., Liu, R. J., Zhang, S., Li, G. Q., Chen, Z. C. & Zhang, P. F. (2018). Ginnalin A from Kujin tea (Acer tataricum subsp. ginnala) exhibits a colorectal cancer chemoprevention effect via activation of the Nrf2/HO-1 signaling pathway. Food & function, 9(5), 2809–2819. https://doi.org/10.1039/c8fo00054a
Board, M., Colquhoun, A. & Newsholme, E. A. (1995). High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose. Cancer research, 55(15), 3278–3285.
Butt, M. S., Naz, A., Sultan, M. T. & Qayyum, M. M. (2013). Anti-oncogenic perspectives of spices/herbs: A comprehensive review. EXCLI journal, 12, 1043–1065.
Caballero Palacios, J. C. (2014). Evaluación fitoquímica y actividad antimicrobiana de Tessaria integrifolia, recurso medicinal del Perú [Tesis doctoral]. Universidad Nacional de Trujillo, Perú.
Campos-Navarro, R. & Scarpa, G. F. (2013). The cultural-bound disease "empacho" in Argentina. A comprehensive botanico-historical and ethnopharmacological review. Journal of ethnopharmacology, 148(2), 349–360. https://doi.org/10.1016/j.jep.2013.05.002
Chan, E., Wong, S. K. & Chan, H. T. (2018). Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties. Journal of integrative medicine, 16(3), 147–152. https://doi.org/10.1016/j.joim.2018.03.001
Correa, C. S., Razco, L. C., Sánchez, C. G., Aquiño, O. C. & Rodríguez, A. M. (2014). Efecto de Tessaria integrifolia R. et P. sobre úlceras gástricas inducidas en Rattus rattus var. albinus. Pharmaciencia, 2(1), 19-23.
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M. & Pinzaru, I. (2021). Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules (Basel, Switzerland), 26(4), 1109. https://doi.org/10.3390/molecules26041109
Deng, Y., Guo, W., Li, G., Li, S., Li, H., Li, X., Niu, B., Song, M., Zhang, Y., Xu, Z. & Li, F. (2020). Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1. Journal of breast cancer, 23(1), 20–35. https://doi.org/10.4048/jbc.2020.23.e7
Donadel, O. J., Guerreiro, E., María, A. O., Wendel, G., Enriz, R. D., Giordano, O. S. & Tonn, C. E. (2005). Gastric cytoprotective activity of ilicic aldehyde: structure-activity relationships. Bioorganic & medicinal chemistry letters, 15(15), 3547–3550. https://doi.org/10.1016/j.bmcl.2005.05.053
Fathy, M., Fawzy, M. A., Hintzsche, H., Nikaido, T., Dandekar, T. & Othman, E. M. (2019). Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation. Molecules (Basel, Switzerland), 24(21), 3979. https://doi.org/10.3390/molecules24213979
Feo, V. D., D'agostino, M., Simone, F. D. & Pizza, C. (1990). Constituents of Tessaria integrifolia. Fitoterapia, 61(5), 474-475.
Fidyt, K., Fiedorowicz, A., Strządała, L. & Szumny, A. (2016). β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer medicine, 5(10), 3007–3017. https://doi.org/10.1002/cam4.816
Furtado, F. B., Borges, B. C., Teixeira, T. L., Garces, H. G., Almeida Junior, L. D., Alves, F., Silva, C. & Fernandes Junior, A. (2018). Chemical Composition and Bioactivity of Essential Oil from Blepharocalyx salicifolius. International journal of molecular sciences, 19(1), 33. https://doi.org/10.3390/ijms19010033
García, C. C., Talarico, L., Almeida, N., Colombres, S., Duschatzky, C. & Damonte, E. B. (2003). Virucidal activity of essential oils from aromatic plants of San Luis, Argentina. Phytotherapy research: PTR, 17(9), 1073–1075. https://doi.org/10.1002/ptr.1305
García, M., Sosa, M. E., Donadel, O. J., Giordano, O. S., & Tonn, C. E. (2003). Allelochemical effects of eudesmane and eremophilane sesquiterpenes on Tribolium castaneum larvae. Journal of chemical ecology, 29(1), 175–187. https://doi.org/10.1023/a:1021988816329
García, M., Donadel, O. J. & Giordano, O. S. (2017). Effects of some sesquiterpenes on the stored-product insect Tenebrio molitor (Coleoptera: Tenebrionidae). Revista de la Sociedad Entomologica Argentina, 62(3-4).
Gómez, J., Simirgiotis, M. J., Lima, B., Gamarra-Luques, C., Bórquez, J., Caballero, D., Feresin, G. E. & Tapia, A. (2019). UHPLC-Q/Orbitrap/MS/MS Fingerprinting, Free Radical Scavenging, and Antimicrobial Activity of Tessaria absinthiodes (Hook. & Arn.) DC. (Asteraceae) Lyophilized Decoction from Argentina and Chile. Antioxidants (Basel, Switzerland), 8(12), 593. https://doi.org/10.3390/antiox8120593
Gong, J., Zhou, S. & Yang, S. (2019). Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells. International journal of molecular sciences, 20(3), 465. https://doi.org/10.3390/ijms20030465
Guerreiro, E., Pestchanker, M. J., Del Vitto, L. & Giordano, O. S. (1990). Sesquiterpenes and flavonoids from Tessaria species. Phytochemistry, 29(3), 877-879. https://doi.org/10.1016/0031-9422(90)80037-H
Hsu, P. C., Cheng, C. F., Hsieh, P. C., Chen, Y. H., Kuo, C. Y. & Sytwu, H. K. (2020). Chrysophanol regulates cell death, metastasis, and reactive oxygen species production in oral cancer cell lines. Evidence-Based Complementary and Alternative Medicine, 2020. https://doi.org/10.1155/2020/5867064
In, J. K., Kim, J. K., Oh, J. S. & Seo, D. W. (2016). 5-Caffeoylquinic acid inhibits invasion of non-small cell lung cancer cells through the inactivation of p70S6K and Akt activity: Involvement of p53 in differential regulation of signaling pathways. International journal of oncology, 48(5), 1907–1912. https://doi.org/10.3892/ijo.2016.3436
Joshi, R., Kulkarni, Y. A. & Wairkar, S. (2018). Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life sciences, 215, 43–56. https://doi.org/10.1016/j.lfs.2018.10.066
Julián Dávalos, M. M. & Vásquez Muñoz, A. A. (2016). Evaluación del efecto histopatológico del infuso de inflorescencias de Tessaria integrifolia r. et. p. sobre órganos de rattus norvegicus var. albinus [Tesis doctoral]. Universidad Nacional de Trujillo, Perú.
Kanarek, N., Petrova, B. & Sabatini, D. M. (2020). Dietary modifications for enhanced cancer therapy. Nature, 579(7800), 507–517. https://doi.org/10.1038/s41586-020-2124-0
Kim, M. J., Kwon, S. B., Kim, M. S., Jin, S. W., Ryu, H. W., Oh, S. R. & Yoon, D. Y. (2016). Trifolin induces apoptosis via extrinsic and intrinsic pathways in the NCI-H460 human non-small cell lung-cancer cell line. Phytomedicine: international journal of phytotherapy and phytopharmacology, 23(10), 998–1004. https://doi.org/10.1016/j.phymed.2016.05.009
Lan, L., Wang, Y., Pan, Z., Wang, B., Yue, Z., Jiang, Z., Li, L., Wang, C. & Tang, H. (2019). Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway. Oncology letters, 17(1), 676–682. https://doi.org/10.3892/ol.2018.9575
Lechner, J. F. & Stoner, G. D. (2019). Red Beetroot and Betalains as Cancer Chemopreventative Agents. Molecules (Basel, Switzerland), 24(8), 1602. https://doi.org/10.3390/molecules24081602
León, L. G., Donadel, O. J., Tonn, C. E. & Padrón, J. M. (2009). Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines. Bioorganic & medicinal chemistry, 17(17), 6251–6256. https://doi.org/10.1016/j.bmc.2009.07.053
Liang, N., Li, Y. & Chung, H. Y. (2017). Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways. International journal of oncology, 51(1), 213–222. https://doi.org/10.3892/ijo.2017.4004
Li, F. R., Yu, F. X., Yao, S. T., Si, Y. H., Zhang, W. & Gao, L. L. (2012). Hyperin extracted from Manchurian rhododendron leaf induces apoptosis in human endometrial cancer cells through a mitochondrial pathway. Asian Pacific journal of cancer prevention: APJCP, 13(8), 3653–3656. https://doi.org/10.7314/apjcp.2012.13.8.3653
Li, W., Du, Q., Li, X., Zheng, X., Lv, F., Xi, X., Huang, G., Yang, J. & Liu, S. (2020). Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway. Frontiers in pharmacology, 11, 114. https://doi.org/10.3389/fphar.2020.00114
Liu, R. H. (2004). Potential synergy of phytochemicals in cancer prevention: mechanism of action. The Journal of nutrition, 134(12 Suppl), 3479S–3485S. https://doi.org/10.1093/jn/134.12.3479S
Madaleno, I. M. & Delatorre-Herrera, J. (2013). Medicina popular de Iquique, Tarapacá. Idesia (Arica), 31(1), 67-78. https://doi.org/10.4067/S0718-34292013000100009
Nanayakkara, N. P., Hussain, R. A., Pezzuto, J. M., Soejarto, D. D. & Kinghorn, A. D. (1988). An intensely sweet dihydroflavonol derivative based on a natural product lead compound. Journal of medicinal chemistry, 31(6), 1250–1253. https://doi.org/10.1021/jm00401a030
Ning, Y., Fu, Y. L., Zhang, Q. H., Zhang, C. & Chen, Y. (2019). Inhibition of in vitro and in vivo ovarian cancer cell growth by pinoresinol occurs by way of inducing autophagy, inhibition of cell invasion, loss of mitochondrial membrane potential and inhibition Ras/MEK/ERK signalling pathway. Journal of B.U.ON.: official journal of the Balkan Union of Oncology, 24(2), 709–714.
Oliveira, R. J., da Cruz Leite Santos, N., Pesarini, J. R., de Oliveira, B. C., Berno, C. R., de Araújo, F., da Silveira, I., Nascimento, R. O., Brochado Antoniolli-Silva, A., Duenhas Monreal, A. C., Beatriz, A., de Lima, D. P. & da Silva Gomes, R. (2018). Assessment of genetic integrity, splenic phagocytosis and cell death potential of (Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid and its effect when combined with commercial chemotherapeutics. Genetics and molecular biology, 41(1), 154–166. https://doi.org/10.1590/1678-4685-GMB-2017-0091
Ono, M., Masuoka, C., Odake, Y., Ikegashira, S., Ito, Y. & Nohara, T. (2007). Antioxidative constituents from Tessaria integrifolia. Food science and technology research, 6(2), 106-114. https://doi.org/10.1016/S0031-9422(99)00580-4
Ono, M., Masuoka, C., Odake, Y., Ito, Y. & Nohara, T. (2000). Eudesmane derivatives from Tessaria integrifolia. Phytochemistry, 53(4), 479-484.
Pan, W. & Zhang, G. (2019). Linalool monoterpene exerts potent antitumor effects in OECM 1 human oral cancer cells by inducing sub-G1 cell cycle arrest, loss of mitochondrial membrane potential and inhibition of PI3K/AKT biochemical pathway. Journal of B.U.ON.: official journal of the Balkan Union of Oncology, 24(1), 323–328.
Parejo, I., Viladomat, F., Bastida, J., Rosas-Romero, A., Saavedra, G., Murcia, M. A., Jiménez, A. M. & Codina, C. (2003). Investigation of Bolivian plant extracts for their radical scavenging activity and antioxidant activity. Life sciences, 73(13), 1667–1681. https://doi.org/10.1016/s0024-3205(03)00488-0
Peluso, G., De Feo, V., De Simone, F., Bresciano, E. & Vuotto, M. L. (1995). Studies on the inhibitory effects of caffeoylquinic acids on monocyte migration and superoxide ion production. Journal of natural products, 58(5), 639–646. https://doi.org/10.1021/np50119a00
Persia, F. A., Rinaldini, E., Carrión, A., Hapon, M. B. & Gamarra-Luques, C. (2017). Evaluation of cytotoxic and antitumoral properties of Tessaria absinthioides (Hook & Arn) DC, "pájaro bobo", aqueous extract. Evaluación de las propiedades citotóxicas y antitumorales del extracto acuoso de Tessaria absinthioides (Hook & Arn) DC, "pájaro bobo". Medicina, 77(4), 283–290.
Piotrowski, I., Kulcenty, K. & Suchorska, W. (2020). Interplay between inflammation and cancer. Reports of practical oncology and radiotherapy: journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 25(3), 422–427. https://doi.org/10.1016/j.rpor.2020.04.004
Piroozmand, F., Mohammadipanah, F. & Faridbod, F. (2020). Emerging biosensors in detection of natural products. Synthetic and systems biotechnology, 5(4), 293–303. https://doi.org/10.1016/j.synbio.2020.08.002
Puccinelli, M. T. & Stan, S. D. (2017). Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment. International journal of molecular sciences, 18(8), 1645. https://doi.org/10.3390/ijms18081645
Qazi, A. K., Siddiqui, J. A., Jahan, R., Chaudhary, S., Walker, L. A., Sayed, Z., Jones, D. T., Batra, S. K. & Macha, M. A. (2018). Emerging therapeutic potential of graviola and its constituents in cancers. Carcinogenesis, 39(4), 522–533. https://doi.org/10.1093/carcin/bgy024
Quesada, I., de Paola, M., Hapon, M.B., Gamarra-Luques. C. & Castro, C. (2021). Antioxidant and anti-atherogenic properties of Prosopis strombulifera and Tessaria absinthioides aqueous extracts: modulation of NADPH-oxidase-derived ROS. Frontiers in Physiology, 12, 886.
Rahman, M. A., Amin, A. R. & Shin, D. M. (2010). Chemopreventive potential of natural compounds in head and neck cancer. Nutrition and cancer, 62(7), 973–987. https://doi.org/10.1080/01635581.2010.509538
Ramchandani, S., Naz, I., Lee, J. H., Khan, M. R. & Ahn, K. S. (2020). An Overview of the Potential Antineoplastic Effects of Casticin. Molecules (Basel, Switzerland), 25(6), 1287. https://doi.org/10.3390/molecules25061287
Razak, N. A., Abu, N., Ho, W. Y., Zamberi, N. R., Tan, S. W., Alitheen, N. B., Long, K. & Yeap, S. K. (2019). Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Scientific reports, 9(1), 1514. https://doi.org/10.1038/s41598-018-37796-w
Rezaei-Seresht, H., Cheshomi, H., Falanji, F., Movahedi-Motlagh, F., Hashemian, M. & Mireskandari, E. (2019). Cytotoxic activity of caffeic acid and gallic acid against MCF-7 human breast cancer cells: An in silico and in vitro study. Avicenna journal of phytomedicine, 9(6), 574–586. https://doi.org/10.22038/AJP.2019.13475
Romero, C. M., Vivacqua, C. G., Abdulhamid, M. B., Baigori, M. D., Slanis, A. C., Allori, M. C. & Tereschuk, M. L. (2016). Biofilm inhibition activity of traditional medicinal plants from Northwestern Argentina against native pathogen and environmental microorganisms. Revista da Sociedade Brasileira de Medicina Tropical, 49(6), 703–712. https://doi.org/10.1590/0037-8682-0452-2016
Ryan, B. M. & Faupel-Badger, J. M. (2016). The hallmarks of premalignant conditions: a molecular basis for cancer prevention. Seminars in oncology, 43(1), 22–35. https://doi.org/10.1053/j.seminoncol.2015.09.007
Serrano, A., Ros, G. & Nieto, G. (2018). Bioactive Compounds and Extracts from Traditional Herbs and Their Potential Anti-Inflammatory Health Effects. Medicines (Basel, Switzerland), 5(3), 76. https://doi.org/10.3390/medicines5030076
Shapira, S., Pleban, S., Kazanov, D., Tirosh, P. & Arber, N. (2016). Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers. PloS one, 11(6), e0156540. https://doi.org/10.1371/journal.pone.0156540
Silva-Correa, C. R. (2011). Actividad antiespasmódica de Tessaria integrifolia r. et p. y Artemisia absinthium l. en íleon aislado de Cavia porcellus [Tesis doctoral]. Universidad Nacional de Trujillo, Perú. 1-40. https://doi.org/10.17843/rpmesp.2018.352.3140
Silva-Correa, C. R., Cruzado-Razco, J. L., González-Blas, M. V., García-Armas, J. M., Ruiz-Reyes, S. G., Torre, V. L., ... & Gamarra-Sánchez, C. D. (2018). Identificación y determinación estructural de un sesquiterpeno de las hojas de Tessaria integrifolia Ruiz & Pav. y evaluación de su actividad Leishmanicida. Revista Peruana de Medicina Experimental y Salud Pública, 35, 221-227.
Slezakova, S. & Ruda-Kucerova, J. (2017). Anticancer Activity of Artemisinin and its Derivatives. Anticancer research, 37(11), 5995–6003. https://doi.org/10.21873/anticanres.12046
Soberón, J. R., Sgariglia, M. A., Carabajal Torrez, J. A., Aguilar, F. A., Pero, E., Sampietro, D. A., Fernández de Luco, J. & Labadie, G. R. (2020). Antifungal activity and toxicity studies of flavanones isolated from Tessaria dodoneifolia aerial parts. Heliyon, 6(10), e05174. https://doi.org/10.1016/j.heliyon.2020.e05174
Sosa, M. E., Tonn, C. E., Guerreiro, E. & Giordano, O. S. (2000). Bioactividad de flavonoides sobre larvas de Tenebrio monitor. Revista de la Sociedad Entomológica Argentina, 59, 179-184.
Stompor M. (2020). A Review on Sources and Pharmacological Aspects of Sakuranetin. Nutrients, 12(2), 513. https://doi.org/10.3390/nu12020513
Tang, S. M., Deng, X. T., Zhou, J., Li, Q. P., Ge, X. X. & Miao, L. (2020). Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 121, 109604. https://doi.org/10.1016/j.biopha.2019.109604
Tariq, A., Sadia, S., Pan, K., Ullah, I., Mussarat, S., Sun, F., Abiodun, O. O., Batbaatar, A., Li, Z., Song, D., Xiong, Q., Ullah, R., Khan, S., Basnet, B. B., Kumar, B., Islam, R. & Adnan, M. (2017). A systematic review on ethnomedicines of anti-cancer plants. Phytotherapy research: PTR, 31(2), 202–264. https://doi.org/10.1002/ptr.5751
The Plant List. (2013). Genus Tessaria. Version 1.1. http://www.theplantlist.org/
Thomas, E., Vandebroek, I., Sanca, S. & Van Damme, P. (2009). Cultural significance of medicinal plant families and species among Quechua farmers in Apillapampa, Bolivia. Journal of ethnopharmacology, 122(1), 60–67. https://doi.org/10.1016/j.jep.2008.11.021
Torres Carro, R., Isla, M. I., Ríos, J. L., Giner, R. M. & Alberto, M. R. (2015). Anti-inflammatory properties of hydroalcoholic extracts of Argentine Puna plants. Food Research International, 67, 230-237. https://doi.org/10.1016/j.foodres.2014.11.012
Torres-Carro, R., Isla, M. I., Thomas-Valdes, S., Jiménez-Aspee, F., Schmeda-Hirschmann, G. & Alberto, M. R. (2017). Inhibition of pro-inflammatory enzymes by medicinal plants from the Argentinean highlands (Puna). Journal of ethnopharmacology, 205, 57–68. https://doi.org/10.1016/j.jep.2017.04.013
Tropicos.org. (1982). Missouri Botanical Garden. Tessaria Ruiz & Pav. https://tropicos.org
Visintini Jaime, M. F., Redko, F., Muschietti, L. V., Campos, R. H., Martino, V. S. & Cavallaro, L. V. (2013). In vitro antiviral activity of plant extracts from Asteraceae medicinal plants. Virology journal, 10, 245. https://doi.org/10.1186/1743-422X-10-245
Wang, R., Zhu, X., Wang, Q., Li, X., Wang, E., Zhao, Q., Wang, Q. & Cao, H. (2020). The anti-tumor effect of taxifolin on lung cancer via suppressing stemness and epithelial-mesenchymal transition in vitro and oncogenesis in nude mice. Annals of translational medicine, 8(9), 590. https://doi.org/10.21037/atm-20-3329
Weinstein, I. B., Gattoni-Celli, S., Kirschmeier, P., Lambert, M., Hsiao, W., Backer, J. & Jeffrey, A. (1984). Multistage carcinogenesis involves multiple genes and multiple mechanisms. Journal of cellular physiology, Supplement, 3, 127–137. https://doi.org/10.1002/jcp.1041210416
Wen, S., Gu, D. & Zeng, H. (2018). Antitumor effects of beta-amyrin in Hep-G2 liver carcinoma cells are mediated via apoptosis induction, cell cycle disruption and activation of JNK and P38 signalling pathways. Journal of B.U.ON.: official journal of the Balkan Union of Oncology, 23(4), 965–970.
Ying, T. H., Chen, C. W., Hsiao, Y. P., Hung, S. J., Chung, J. G. & Yang, J. H. (2013). Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase- and mitochondrial-dependent signaling pathways. Anticancer research, 33(10), 4411–4420.
Yongram, C., Sungthong, B., Puthongking, P. & Weerapreeyakul, N. (2019). Chemical Composition, Antioxidant and Cytotoxicity Activities of Leaves, Bark, Twigs and Oleo-Resin of Dipterocarpus alatus. Molecules (Basel, Switzerland), 24(17), 3083. https://doi.org/10.3390/molecules24173083
Arianna Sosa-Lochedino, ariannasosalochedino@gmail.com, https://orcid.org/0000-0002-5338-1412
María Belén Hapon, bhapon@mendoza-conicet.gob.ar, https://orcid.org/0000-0003-4381-5368
Carlos Gamarra-Luques, cgamarraluques@gmail.com, https://orcid.org/0000-0003-1746-9174
* Corresponding author
1 Instituto de Medicina y Biología Experimental de Cuyo (IMBECU) – UNCuyo, CCT Mendoza, CONICET. CP5500. Mendoza, Argentina.
2 Universidad Nacional de Cuyo, Facultad de Ciencias Exactas y Naturales. CP5500. Mendoza, Argentina.
3 Universidad Nacional de Cuyo, Facultad de Ciencias Médicas. CP5500. Mendoza, Argentina.
A Systematic Review About the Contribution of The Genus Tessaria (Asteraceae) To Cancer Study and Treatment (Arianna Sosa-Lochedino • María Belén Hapon • Carlos Gamarra-Luques) in Uniciencia is protected by Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0)
URL: www.revistas.una.ac.cr/uniciencia
Correo electrónico: revistauniciencia@una.cr